182 related articles for article (PubMed ID: 18670671)
1. [Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy].
Meiners CM
Cad Saude Publica; 2008 Jul; 24(7):1467-78. PubMed ID: 18670671
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
3. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
Guennif S
Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
[TBL] [Abstract][Full Text] [Related]
5. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
6. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
Viana JM
Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
[No Abstract] [Full Text] [Related]
7. Making tenofovir accessible in the brazilian public health system: patent conflicts and generic production.
Veras J
Dev World Bioeth; 2014 Aug; 14(2):92-100. PubMed ID: 24889312
[TBL] [Abstract][Full Text] [Related]
8. [Brazilian policy for the distribution and production of antiretroviral drugs: a privilege or a right?].
Galvao J
Cad Saude Publica; 2002; 18(1):213-9. PubMed ID: 11910440
[TBL] [Abstract][Full Text] [Related]
9. Access to antiretroviral drugs in Brazil.
Galvão J
Lancet; 2002 Dec; 360(9348):1862-5. PubMed ID: 12480377
[TBL] [Abstract][Full Text] [Related]
10. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
Ferreira L
Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
[No Abstract] [Full Text] [Related]
11. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
12. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
14. Changes to intellectual property policy in South Africa: putting a stop to evergreening?
Hill JE
Expert Opin Ther Pat; 2014 Aug; 24(8):839-43. PubMed ID: 24965317
[TBL] [Abstract][Full Text] [Related]
15. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
Attaran A; Gillespie-White L
JAMA; 2001 Oct; 286(15):1886-92. PubMed ID: 11597292
[TBL] [Abstract][Full Text] [Related]
16. Academic patents and access to medicines in developing countries.
Sampat BN
Am J Public Health; 2009 Jan; 99(1):9-17. PubMed ID: 19008514
[TBL] [Abstract][Full Text] [Related]
17. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
Cohen JC; Illingworth P
Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
[TBL] [Abstract][Full Text] [Related]
18. Expanding drug access in Brazil: lessons for Latin America and Canada.
Cohen JC
Can J Public Health; 2006; 97(6):I15-8. PubMed ID: 17203728
[TBL] [Abstract][Full Text] [Related]
19. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
20. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
Torres MA
Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
